Phase I Study of Pazopanib in Combination With Vinorelbine in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC) and Breast Cancer.
Phase of Trial: Phase I
Latest Information Update: 29 Oct 2013
At a glance
- Drugs Pazopanib (Primary) ; Vinorelbine (Primary)
- Indications Advanced breast cancer; Non-small cell lung cancer
- Focus Adverse reactions
- 01 Sep 2013 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 17 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 27 Jul 2011 Status changed from suspended to recruiting as reported by ClinicalTrials.gov.